Brought to you by 
Microbia gets $26mm with private placement
03 Jun 2003
Executive Summary
Microbia (antimicrobial drugs) has raised $26mm with its Series C private placement of shares to lead investor Fidelity BioSciences Group (managed by Fidelity Investments). Existing institutional investors Venrock Associates, Polaris Venture Partners, Essex Investment Management Co., Aberdare Ventures, and BancBoston Ventures, and other private investors also participated.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Microbia gets $26mm with private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice